BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34610185)

  • 41. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients.
    Mimoz O; Pieroni L; Lawrence C; Edouard A; Costa Y; Samii K; Brun-Buisson C
    Crit Care Med; 1996 Nov; 24(11):1818-23. PubMed ID: 8917031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy.
    Tsai HC; Huang LM; Chang LY; Lee PI; Chen JM; Shao PL; Hsueh PR; Sheng WH; Chang YC; Lu CY
    J Microbiol Immunol Infect; 2015 Dec; 48(6):639-46. PubMed ID: 25311403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lower risk of bloodstream infections for peripherally inserted central catheters compared to central venous catheters in critically ill patients.
    Pitiriga V; Bakalis J; Theodoridou K; Kanellopoulos P; Saroglou G; Tsakris A
    Antimicrob Resist Infect Control; 2022 Nov; 11(1):137. PubMed ID: 36352414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of hospital-acquired bloodstream infections through chlorhexidine gluconate-impregnated washcloth bathing in intensive care units: a systematic review and meta-analysis of randomised crossover trials.
    Afonso E; Blot K; Blot S
    Euro Surveill; 2016 Nov; 21(46):. PubMed ID: 27918269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
    Gilbert R; Brown M; Faria R; Fraser C; Donohue C; Rainford N; Grosso A; Sinha AK; Dorling J; Gray J; Muller-Pebody B; Harron K; Moitt T; McGuire W; Bojke L; Gamble C; Oddie SJ
    Health Technol Assess; 2020 Nov; 24(57):1-190. PubMed ID: 33174528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Central venous access device Securement and dressing effectiveness: The CASCADE pilot randomised controlled trial in the adult intensive care.
    Mitchell ML; Ullman AJ; Takashima M; Davis C; Mihala G; Powell M; Gibson V; Zhang L; Bauer M; Geoffrey Playford E; Rickard CM
    Aust Crit Care; 2020 Sep; 33(5):441-451. PubMed ID: 31757717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polyhexamethylene biguanide discs versus unmedicated dressings for prevention of central venous catheter-associated infection in the intensive care unit: A pilot randomised controlled trial to assess protocol safety and feasibility.
    Pearse I; Marsh N; Rickard CM; Ullman AJ; Larsen E; Pelecanos A; McGuinness N; Irvine L; Rapchuk IL; Ziegenfuss M; Corley A
    Aust Crit Care; 2022 Sep; 35(5):512-519. PubMed ID: 34321181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Infectious risk associated with arterial catheters compared with central venous catheters.
    Lucet JC; Bouadma L; Zahar JR; Schwebel C; Geffroy A; Pease S; Herault MC; Haouache H; Adrie C; Thuong M; Français A; Garrouste-Orgeas M; Timsit JF
    Crit Care Med; 2010 Apr; 38(4):1030-5. PubMed ID: 20154601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative Effectiveness of 2 Chlorhexidine Gluconate-Containing Dressings in Reducing Central Line-Associated Bloodstream Infections, Hospital Stay, and Costs.
    Hou Y; Griffin L; Bernatchez SF; Hommes J; Kärpänen T; Palka-Santini M
    Inquiry; 2023; 60():469580231214751. PubMed ID: 38037829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit.
    Osma S; Kahveci SF; Kaya FN; Akalin H; Ozakin C; Yilmaz E; Kutlay O
    J Hosp Infect; 2006 Feb; 62(2):156-62. PubMed ID: 16307824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strategies for the prevention of central venous catheter infections: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review.
    Huang EY; Chen C; Abdullah F; Aspelund G; Barnhart DC; Calkins CM; Cowles RA; Downard CD; Goldin AB; Lee SL; St Peter SD; Arca MJ;
    J Pediatr Surg; 2011 Oct; 46(10):2000-11. PubMed ID: 22008341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness of chlorhexidine dressings to prevent catheter-related bloodstream infections. Does one size fit all? A systematic literature review and meta-analysis.
    Puig-Asensio M; Marra AR; Childs CA; Kukla ME; Perencevich EN; Schweizer ML
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1388-1395. PubMed ID: 32935659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis.
    Ho KM; Litton E
    J Antimicrob Chemother; 2006 Aug; 58(2):281-7. PubMed ID: 16757502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis.
    Yamaguchi RS; Noritomi DT; Degaspare NV; Muñoz GOC; Porto APM; Costa SF; Ranzani OT
    Intensive Care Med; 2017 Aug; 43(8):1097-1104. PubMed ID: 28584925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial.
    Ruschulte H; Franke M; Gastmeier P; Zenz S; Mahr KH; Buchholz S; Hertenstein B; Hecker H; Piepenbrock S
    Ann Hematol; 2009 Mar; 88(3):267-72. PubMed ID: 18679683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early prophylaxis of central venous catheter-related thrombosis using 1% chlorhexidine gluconate and chlorhexidine-gel-impregnated dressings: a retrospective cohort study.
    Yamashita T; Takamori A; Nakagawachi A; Tanigawa Y; Hamada Y; Aoki Y; Sakaguchi Y
    Sci Rep; 2020 Sep; 10(1):15952. PubMed ID: 32994455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chlorhexidine (di)gluconate locking device for central line infection prevention in intensive care unit patients: a multi-unit, pilot randomized controlled trial.
    Pook M; Zamir N; McDonald E; Fox-Robichaud A
    Br J Nurs; 2022 Jul; 31(14):S36-S46. PubMed ID: 35856588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of microbial colonization rates between central venous catheters and peripherally inserted central catheters.
    Pitiriga V; Bakalis J; Theodoridou K; Dimitroulia E; Saroglou G; Tsakris A
    Antimicrob Resist Infect Control; 2023 Aug; 12(1):74. PubMed ID: 37550791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review.
    Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
    Int J Nurs Stud; 2016 Jul; 59():177-96. PubMed ID: 27222463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arterial catheter-related bloodstream infection: incidence, pathogenesis, risk factors and prevention.
    Safdar N; O'Horo JC; Maki DG
    J Hosp Infect; 2013 Nov; 85(3):189-95. PubMed ID: 24070632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.